Infliximab in refractory spondyloarthropathies:: a multicentre 38 week open study

被引：27

作者：

Collantes-Estévez, E

Muñoz-Villanueva, MC

Cañete-Crespillo, JD

Sanmartí-Sala, R

Gratacós-Masmitjá, J

Zarco-Montejo, P

Torre-Alonso, JC

González-Fernández, C

机构：

[1] Hosp Univ Reina Sofia, Serv Reumatol, Cordoba 14011, Spain

[2] Hosp Univ Reina Sofia, Res Unit, Cordoba 14011, Spain

[3] Hosp Clin Barcelona, Rheumatol Serv, Barcelona, Spain

[4] Parc Tauli Hosp, Rheumatol Serv, Sabadell, Spain

[5] Alcorcon Fdn Hosp, Rheumatol Serv, Madrid, Spain

[6] Monte Naranco Hosp, Rheumatol Serv, Oviedo, Spain

[7] Gregorio Maranon Hosp, Rheumatol Serv, Madrid, Spain

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷 / 12期

关键词：

D O I：

10.1136/ard.2002.004879

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1239 / 1240

页数：2

共 9 条

[1]

AMOR B, 1995, RHEUM DIS CLIN N AM, V21, P117

[2]

Anderson JJ, 2001, ARTHRITIS RHEUM-US, V44, P1876, DOI 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO

[3]

2-F

[4]

Braun J, 2002, ANN RHEUM DIS, V61, P51

[5] Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].

Braun, J ;

Brandt, J ;

Listing, J ;

Zink, A ;

Alten, R ;

Golder, W ;

Gromica-Ihle, E ;

Kellner, H ;

Krause, A ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Thriene, W ;

Sieper, J .

LANCET, 2002, 359 (9313) :1187-1193

[6]

Dougados M, 2001, J RHEUMATOL, V28, P16

[7] Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy [J].

Van den Bosch, F ;

Kruithof, E ;

Baeten, D ;

Herssens, A ;

de Keyser, F ;

Mielants, H ;

Veys, EM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :755-765

[8] THE MOS 36-ITEM SHORT-FORM HEALTH SURVEY (SF-36) .1. CONCEPTUAL-FRAMEWORK AND ITEM SELECTION [J].

WARE, JE ;

SHERBOURNE, CD .

MEDICAL CARE, 1992, 30 (06) :473-483

[9]

Zink A, 2000, J RHEUMATOL, V27, P613

← 1 →